Pharmaceuticals News and Research

RSS

Study shows new atopic dermatitis therapy significantly delays onset of flares

Stiefel Laboratories, the world's largest independent pharmaceutical company specializing in dermatology, announced that a recent study shows MimyX Cream extends the remission period of atopic dermatitis (AD) by 48 percent when used in conjunction with an emollient compared to emollient alone.

6 Mar 2006

Orthopaedic medical device technologies that offer greater clinical benefits expected to succeed

Current users of medical device technologies for orthopaedic applications seek systems that offer maximum comfort while requiring minimum physical supervision. This is driving the market to continuously evolve technologies that use radically different approaches or make significant improvements to existing products.

6 Mar 2006

Trials on MS drug Tysabri renews hope for sufferers

According to the results of two new trials the multiple sclerosis (MS) drug Tysabri significantly reduces the progression of the disease.

5 Mar 2006

Rhodium quinones promise better drugs

By combining a common organic compound with a rare metal, a team of Brown University chemists has created a new class of molecules that have potentially important applications for the pharmaceutical, chemical and energy industries.

1 Mar 2006

FDA shields drug companies from lawsuits

Last month, the FDA revealed its latest protective policy for drug companies in a statement that said people who believe they have been injured by drugs approved by the FDA should not be allowed to sue drug companies in state courts.

1 Mar 2006

Crystal meth the new drug pandemic

According to a U.N. narcotics watchdog the synthetic drug methamphetamine is a bigger problem in the United States and other countries than either heroin or cocaine.

1 Mar 2006

Clinical trial of new Bionovo menopause drug moves forward

Today, millions of women suffer from often-harsh symptoms of menopause such as hot flashes and night sweats -- and relief is nowhere to be found.

27 Feb 2006

Ginkgo biloba reduces aggressive cancer risk in animal experiments

Researchers at Georgetown University Medical Center say they now have a clearer picture of how an extract from the leaves of the Ginkgo biloba tree reduces the risk of aggressive cancer in animal experiments.

27 Feb 2006

Teatments based on behaviour could reduce prescription drug use

New psychological treatments - behavioural medicine - could significantly reduce the need for drug treatments for some conditions, cutting health system costs says an editorial in this week's British Medical Journal.

27 Feb 2006

Chromium industry withheld data from the U.S. government

According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.

27 Feb 2006

Takeda wins patent infringement case

Takeda Pharmaceutical Company Limited and its wholly owned subsidiary, Takeda Pharmaceuticals North America, Inc. have announced that Takeda's intellectual property rights have been successfully asserted against generic manufacturers seeking to challenge Takeda's patent rights to ACTOS (pioglitazone HCl).

24 Feb 2006

Angiotech to appeal judgement regarding UK patent

Angiotech Pharmaceuticals has announced that it intends to appeal a UK trial court decision to revoke Angiotech's UK designation of its European Patent No. 0,706,376.

24 Feb 2006

Singulair pill shows more promise for obese people

As the nation's collective waistline has swelled in recent decades, rates of asthma diagnoses also have accelerated. Indeed, much research has affirmed a link between the two conditions.

23 Feb 2006

Two drug giants team up to develop new bird flu therapy

Two major drug companies have teamed up in order to develop a treatment for pandemic flu strains.

22 Feb 2006

Rotavirus vaccine given the green light

The Food and Drug Administration in the U.S. has recommended a new vaccine for routine use against rotavirus infection.

22 Feb 2006

Dynamic duo, Clinton and India join forces to fight HIV/AIDS

Bill Clinton, in a joint venture with the Indian government is about to embark on another initiative in the fight against HIV/AIDS.

21 Feb 2006

Medical research must put public interests before commercial decisions

Doctors employed by pharmaceutical companies must always put the best interests of patients before their medical research, even if it brings them into conflict with their employers, according to new practical advice from the Faculty of Pharmaceutical Medicine published in the February issue of International Journal of Clinical Practice (IJCP).

21 Feb 2006

Demographic and economic consequences of anti-aging therapies

In the 21st century, state-of-the-art anti-aging technologies may extend human lifespans at an unprecedented rate, bringing with them a host of social and economic challenges, says biologist Shripad Tuljapurkar of Stanford University.

20 Feb 2006

Farnesyltransferase inhibitor may improve progeria

UCLA researchers found that an experimental cancer drug improves the signs of progeria in a mouse model. Progeria is a rare genetic disease causing accelerated aging and cardiovascular disease in children. The new UCLA findings help to define a new strategy for treating children with progeria.

17 Feb 2006

Advancing knowledge of diet-gene interactions

Josi Ordovas, PhD, director of the Nutrition and Genomics Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University joined more than eighty other leading researchers in the fields of nutrition and genetics to co-author a report outlining their strategy for maximizing the impact of nutrigenomics research on global poverty and health.

16 Feb 2006